Skip to content
the Reframe teamFeb 8, 2024 3:15:48 PM1 min read

Cancer Waiting Times: An Invisible Toll on UK Businesses

The latest NHS waiting time statistics paint a concerning picture with over 100,000 patients in 2023 waiting longer than they should to receive treatment with just 64.1% of patients starting treatment within the 62 day NHS target.

Cancer doesn't just impact individuals, it carries hidden costs for businesses too. 

These delays have a ripple effect, impacting employee wellbeing, productivity, and ultimately, the bottom line.

Lost productivity: Imagine a key employee sidelined for months, unable to work while awaiting diagnosis and treatment. Projects stall, deadlines shift, and the team scrambles to cover the workload. This lost productivity ripples through businesses, impacting revenue, morale, and even client relationships.

Financial burden: Cancer treatment involves not just physical but also financial strain. Employees facing cancer may struggle with reduced work hours, impacting income and potentially leading to reliance on sick leave or other benefits. This can put a strain on the company's resources and create additional stress for colleagues.

Uncertainty and morale: Witnessing a colleague battle cancer takes a toll on the entire team. Fear, empathy, and uncertainty can affect focus, communication, and overall workplace morale. Businesses need to prioritise support systems and open communication to navigate this sensitive time.

The cost of delay: Early diagnosis and treatment are crucial for better cancer outcomes. Delays not only impact individual health but also lead to potentially higher treatment costs down the line. Investing in preventative measures and early intervention programmes can benefit both employees and the bottom line.

Cancer waiting list pressure is a significant issue for UK business. It impacts in many ways, some less visible than others and with over 1000 people each day receiving a cancer diagnosis the commercial implications should not be underestimated.